Skip to main content
PMC home page
Applied Microbiology logoLink to Applied Microbiology
. 1971 Dec;22(6):1119–1122. doi: 10.1128/am.22.6.1119-1122.1971

Cell Line Derived from a Murine Sarcoma Virus (Moloney Pseudotype)-Induced Tumor: Cultural, Antigenic, and Virological Properties

J G Massicot 1, W A Woods 1, M A Chirigos 1
PMCID: PMC376495  PMID: 4332935

Abstract

A cell line derived from a murine sarcoma virus (Moloney pseudotype)-induced tumor has been established. It retains oncogenicity, releases both sarcoma and leukemia viruses, and has virus-induced cellular antigens.

Full text

PDF

Images in this article

1120Image
on p.1120
1121Image
on p.1121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barski G., Youn J. K. Evolution of cell-mediated immunity in mice bearing an antigenic tumor. Influence of tumor growth and surgical removal. J Natl Cancer Inst. 1969 Jul;43(1):111–121. [PubMed] [Google Scholar]
  2. Canty T. G., Wunderlich J. R. Quantitative in vitro assay of cytotoxic cellular immunity. J Natl Cancer Inst. 1970 Oct;45(4):761–772. [PubMed] [Google Scholar]
  3. Hellström I., Hellström K. E., Evans C. A., Heppner G. H., Pierce G. E., Yang J. P. Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens. Proc Natl Acad Sci U S A. 1969 Feb;62(2):362–368. doi: 10.1073/pnas.62.2.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Jonsson N. Cell-mediated and humoral immune reactions against tumour-specific and viral antigens in relation to Rous sarcoma virus tumorigenesis in rats. Acta Pathol Microbiol Scand. 1969;77(4):753–755. doi: 10.1111/j.1699-0463.1969.tb04518.x. [DOI] [PubMed] [Google Scholar]
  5. Kikuchi K., Reiner J., Southam C. M. Diffusible cytotoxic substances and cell-mediated resistance to syngeneic tumors: in vitro demonstration. Science. 1968 Jul 4;165(3888):77–79. [PubMed] [Google Scholar]
  6. Pearson G. R., Hodes R. J., Friberg S. Cytotoxic potential of different lymphoid cell populations against chromium-51 labelled tumour cells. Clin Exp Immunol. 1969 Sep;5(3):273–284. [PMC free article] [PubMed] [Google Scholar]
  7. Ramming K. P., Pilch Y. H. Transfer of tumor-specific immunity with RNA: demonstration by immune cytolysis of tumor cells in vitro. J Natl Cancer Inst. 1970 Sep;45(3):543–553. [PubMed] [Google Scholar]
  8. Rowe W. P., Pugh W. E., Hartley J. W. Plaque assay techniques for murine leukemia viruses. Virology. 1970 Dec;42(4):1136–1139. doi: 10.1016/0042-6822(70)90362-4. [DOI] [PubMed] [Google Scholar]
  9. SANDERSON A. R. APPLICATIONS OF ISO-IMMUNE CYTOLYSIS USING RADIOLABELLED TARGET CELLS. Nature. 1964 Oct 17;204:250–253. doi: 10.1038/204250a0. [DOI] [PubMed] [Google Scholar]
  10. SVOBODA J., CHYLE P., SIMKOVIC D., HILGERT I. Demonstration of the absence of infectious Rous virus in rat tumour XC, whose structurally intact cells produce Rous sarcoma when transferred to chicks. Folia Biol (Praha) 1963 Apr;9:77–81. [PubMed] [Google Scholar]
  11. Woods W. A., Massicot J., Chirigos M. A. An immunofluorescent focus assay for gross leukemia virus. Proc Soc Exp Biol Med. 1970 Dec;135(3):772–777. doi: 10.3181/00379727-135-35141. [DOI] [PubMed] [Google Scholar]

Articles from Applied Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES